The exome represents less than 1.5% of the genetic code, but contains ~85% of known disease-related variants. Exome-seq is a cost-effective alternative to whole-genome sequencing applied across a wide range of applications, including population genetics, genetic disease and cancer studies.
Exome-seq
Certified
In combination with SureSelect Exome, linked-reads technology from 10X Genomics allows to call and phase variants across the entire exome and provide accessibility to low complexity or repetitive regions, which short reads alone fail to resolve.
READ MORE